Zhanhui Ou

3.4k total citations · 2 hit papers
32 papers, 2.6k citations indexed

About

Zhanhui Ou is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Zhanhui Ou has authored 32 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Pediatrics, Perinatology and Child Health and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Zhanhui Ou's work include Prenatal Screening and Diagnostics (10 papers), Reproductive Biology and Fertility (9 papers) and CRISPR and Genetic Engineering (9 papers). Zhanhui Ou is often cited by papers focused on Prenatal Screening and Diagnostics (10 papers), Reproductive Biology and Fertility (9 papers) and CRISPR and Genetic Engineering (9 papers). Zhanhui Ou collaborates with scholars based in China and United States. Zhanhui Ou's co-authors include Xiaofang Sun, Xiaohua Niu, Daolin Tang, Rui Kang, De Chen, Ruochan Chen, Min Xie, Li Cao, Yumei Fan and Haichao Wang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Zhanhui Ou

27 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells

2015 1.6k citations Xiaofang Sun, Zhanhui Ou et al. Hepatology profile →
HSPB1 as a novel regulator of ferroptotic cancer cell death

2015 520 citations Xiaofang Sun, Zhanhui Ou et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhanhui Ou China	12	1.8k	1.6k	1.2k	244	148	32	2.6k
Xiaohua Niu China	12	2.2k 1.2×	2.1k 1.3×	1.6k 1.3×	358 1.5×	184 1.2×	16	3.1k
Yuelong Yan United States	11	2.1k 1.1×	2.1k 1.3×	1.6k 1.3×	335 1.4×	183 1.2×	18	3.1k
Bettina Proneth Germany	19	1.6k 0.9×	1.6k 1.0×	1.2k 1.0×	237 1.0×	127 0.9×	26	2.7k
Shang-Jui Wang United States	13	2.7k 1.5×	2.5k 1.5×	2.1k 1.8×	721 3.0×	185 1.3×	29	4.0k
Bo Chu China	17	1.8k 1.0×	1.8k 1.1×	1.5k 1.3×	318 1.3×	110 0.7×	28	2.7k
Omid Tavana United States	19	2.0k 1.1×	1.2k 0.7×	1.1k 0.9×	755 3.1×	184 1.2×	26	2.8k
Vladislav O. Sviderskiy United States	8	1.5k 0.8×	672 0.4×	764 0.6×	244 1.0×	502 3.4×	14	2.1k
Jongchan Kim United States	18	1.8k 1.0×	822 0.5×	1.4k 1.2×	435 1.8×	130 0.9×	34	2.5k
Melissa A. Roberts United States	8	2.0k 1.1×	2.1k 1.3×	1.5k 1.3×	286 1.2×	132 0.9×	10	2.9k

Countries citing papers authored by Zhanhui Ou

Since Specialization

Citations

This map shows the geographic impact of Zhanhui Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanhui Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanhui Ou more than expected).

Fields of papers citing papers by Zhanhui Ou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanhui Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanhui Ou. The network helps show where Zhanhui Ou may publish in the future.

Co-authorship network of co-authors of Zhanhui Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanhui Ou. A scholar is included among the top collaborators of Zhanhui Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanhui Ou. Zhanhui Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Zhiming, et al.. (2025). Evaluation of day 5 versus day 6 blastocyst biopsy in preimplantation genetic testing: clinical and neonatal outcomes. Frontiers in Endocrinology. 16. 1544009–1544009.

Wen, Xiaojun, et al.. (2024). Feasibility of preimplantation genetic testing for aneuploidy on frozen-thawed embryos following conventional IVF insemination. Frontiers in Endocrinology. 15. 1441014–1441014. 1 indexed citations

Ou, Zhanhui, et al.. (2024). Effects of preimplantation genetic testing for aneuploidy on embryo transfer outcomes in women of advanced reproductive age with no more than three retrieved oocytes. Fertility and Sterility. 123(6). 991–998. 1 indexed citations

Ou, Zhanhui, et al.. (2024). The impact of low oocyte maturity ratio on blastocyst euploidy rate: a matched retrospective cohort study. SHILAP Revista de lepidopterología. 9(1). 41–41.

Ou, Zhanhui, et al.. (2023). Effects of reduced follicle-stimulating hormone dosage before human chorionic gonadotropin trigger on in vitro fertilization outcomes. BMC Pregnancy and Childbirth. 23(1). 612–612. 1 indexed citations

Wen, Xiaojun, et al.. (2023). Case report: Preimplantation genetic testing for X-linked alport syndrome caused by variation in the COL4A5 gene. Frontiers in Pediatrics. 11. 1177019–1177019.

Ou, Zhanhui, et al.. (2022). Using affected embryos to establish linkage phase in preimplantation genetic testing for thalassemia. Reproductive Biology and Endocrinology. 20(1). 75–75. 9 indexed citations

Ou, Zhanhui, et al.. (2022). Improved Non-Invasive Preimplantation Genetic Testing for Beta-Thalassemia Using Spent Embryo Culture Medium Containing Blastocoelic Fluid. Frontiers in Endocrinology. 12. 793821–793821. 11 indexed citations

Yang, Yi, Xiangjin Kang, Shiqi Hu, et al.. (2021). CRISPR/Cas9-mediated β-globin gene knockout in rabbits recapitulates human β-thalassemia. Journal of Biological Chemistry. 296. 100464–100464. 9 indexed citations

10.

Xian, Yexing, Yingjun Xie, Bing Song, et al.. (2020). The safety and effectiveness of genetically corrected iPSCs derived from β-thalassaemia patients in nonmyeloablative β-thalassaemic mice. Stem Cell Research & Therapy. 11(1). 288–288. 4 indexed citations

11.

Ou, Zhanhui, et al.. (2020). Re-analysis of whole blastocysts after trophectoderm biopsy indicated chromosome aneuploidy. Human Genomics. 14(1). 3–3. 21 indexed citations

12.

Ou, Zhanhui, et al.. (2019). Influence of different post-thaw culture timeon the clinical outcomes of different quality embryos. Advances in Clinical and Experimental Medicine. 28(4). 523–527. 5 indexed citations

13.

Xie, Yingjun, Yi Yang, Yexing Xian, et al.. (2018). CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells. Stem Cells and Development. 27(11). 756–770. 52 indexed citations

14.

Ou, Zhanhui, et al.. (2017). High-mobility group box 1 regulates cytoprotective autophagy in a mouse spermatocyte cell line (GC-2spd) exposed to cadmium. Irish Journal of Medical Science (1971 -). 186(4). 1041–1050. 8 indexed citations

15.

Niu, Xiaohua, Wenyin He, Bing Song, et al.. (2016). Combining Single Strand Oligodeoxynucleotides and CRISPR/Cas9 to Correct Gene Mutations in β-Thalassemia-induced Pluripotent Stem Cells. Journal of Biological Chemistry. 291(32). 16576–16585. 72 indexed citations

16.

Ou, Zhanhui, Xiaohua Niu, Wenyin He, et al.. (2016). The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice. Scientific Reports. 6(1). 32463–32463. 60 indexed citations

17.

Sun, Xiaofang, Zhanhui Ou, Ruochan Chen, et al.. (2015). Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 63(1). 173–184. 1566 indexed citations breakdown →

18.

Sun, Xiaofang, Zhanhui Ou, Min Xie, et al.. (2015). HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene. 34(45). 5617–5625. 520 indexed citations breakdown →

19.

Song, Bing, Yong Fan, Wenyin He, et al.. (2014). Improved Hematopoietic Differentiation Efficiency of Gene-Corrected Beta-Thalassemia Induced Pluripotent Stem Cells by CRISPR/Cas9 System. Stem Cells and Development. 24(9). 1053–1065. 118 indexed citations

20.

Fan, Yong, Yonghua Jiang, Xinjie Chen, et al.. (2011). Derivation of Cloned Human Blastocysts by Histone Deacetylase Inhibitor Treatment After Somatic Cell Nuclear Transfer with β-Thalassemia Fibroblasts. Stem Cells and Development. 20(11). 1951–1959. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact